Gene: ZBED4
Official Full Name: zinc finger BED-type containing 4provided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in positive regulation of transcription by RNA polymerase II. Located in cytoplasm and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32568 | ZBED4 Knockout cell line (HeLa) | Human | ZBED4 | 1:3~1:6 | Negative | Online Inquiry |
KO32569 | ZBED4 Knockout cell line (HCT 116) | Human | ZBED4 | 1:2~1:4 | Negative | Online Inquiry |
KO32570 | ZBED4 Knockout cell line (HEK293) | Human | ZBED4 | 1:3~1:6 | Negative | Online Inquiry |
KO32571 | ZBED4 Knockout cell line (A549) | Human | ZBED4 | 1:3~1:4 | Negative | Online Inquiry |
ZBED4 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of the ZBED4 gene and its associated biological functions. ZBED4, known for its role in cellular processes such as gene regulation, chromatin remodeling, and the modulation of transcriptional networks, is increasingly recognized for its impact on various diseases, including cancer. These knockout cell lines are created using cutting-edge CRISPR-Cas9 gene editing technology, which ensures that the targeted gene is effectively disrupted, allowing researchers to observe the consequent phenotypic and molecular changes.
The key function of these cell lines lies in their ability to provide insights into ZBED4’s role within the cellular environment. By observing the resultant cellular behavior, researchers can elucidate the gene's involvement in pathways such as cellular proliferation, differentiation, and apoptosis. This makes the ZBED4 Gene Knockout Cell Lines invaluable in both basic research and clinical studies, as they offer a platform for drug discovery, understanding disease mechanisms, and exploring therapeutic targets.
One of the primary advantages of using ZBED4 Gene Knockout Cell Lines is their specificity and reliability over alternative methods such as transient transfection or siRNA-mediated knockdown, which may show variable results. The CRISPR-Cas9 approach provides a permanent and stable alteration of the genome, allowing for long-term studies of gene function and its effects on cellular phenotypes. Moreover, these cell lines are compatible with various experimental conditions, making them versatile for a wide range of applications, including high-throughput screening and detailed pathway analysis.
Researchers and clinicians seeking to deepen their understanding of ZBED4 and its role in disease progression will find these cell lines crucial for their work. They provide a clear and definitive approach to understanding gene function in a systematic manner, opening avenues for potential therapeutic interventions.
Our company, with extensive experience in the development of innovative genetic models, is committed to providing high-quality biological products that empower researchers in their quest to unravel complex biological systems, ensuring that they have the tools needed to drive discoveries in molecular and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.